Training Your Staff on Multifocal IOLs

Properly training your staff is crucial to educating your patients about multifocal IOLs like the AcrySof® IQ ReSTOR® family of IOLs. If your staff members truly believe that a patient will benefit from a multifocal lens, they’ll pass that confidence on to your patient, who in turn may be more willing to believe in the lens.

Creating consistent messaging around multifocal lenses for all staff and referring physicians not only fosters confidence at every level of your practice but also reduces the risk of generating mismatched expectations in patients.

*Dr. Stephen Scoper discusses how designating a staff member to discuss pricing with patients can leave you confident to recommend the lens you feel is best without feeling like a salesperson.
Dr. Stephen Scoper discusses how designating a staff member to discuss pricing with patients can leave you confident to recommend the lens you feel is best without feeling like a salesperson.
Dr. Stephen Scoper discusses how designating a staff member to discuss pricing with patients can leave you confident to recommend the lens you feel is best without feeling like a salesperson.

Keys to preparing your staff for multifocal IOL patients

Conduct regular staff training.

  • Discuss benefits and challenges of multifocal technology.
  • Explain criteria used to assess a patient candidacy.
  • Assess your practice’s progress during weekly/monthly staff meetings.
  • Involve your local Alcon Account Manager for additional product training.

Remind your staff members that they play an important role.

  • Let them know you depend on them.
  • Show them that they’re appreciated and vital to the process.
  • Multifocal lens implantation is merely a step in the patient journey.

Designate a staff member to conduct conversations on pricing specifics.

  • You and the rest of the staff can focus on the benefits of multifocal IOLs.

Disseminate lists or scripts on recommended language.

  • Visual recovery happens over time, not immediately.
  • Some visual disturbances should be expected initially.
  • In most cases they diminish over time.1
  • Don't suggest that patients' vision will be the same as or better than it was in their youth.
  • Don't promise 20/20 vision.

Encourage your staff to provide educational materials to referring physicians.

  • Share success stories.
  • Let them know that they're doing great work that's changing their patients' lives.

 

View Important Product Information for
AcrySof® IQ ReSTOR® Family of IOLs +

ACRYSOF® IQ RESTOR® FAMILY OF INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Lens (IOL) is intended for primary implantation for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia, and ensure that IOL centration is achieved. Care should be taken to remove viscoelastic from the eye at the close of surgery.

Some patients may experience visual disturbances and/or discomfort due to multifocality, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. Spectacle independence rates vary with all multifocal IOLs; as such, some patients may need glasses when reading small print or looking at small objects.

Clinical studies with the AcrySof® ReSTOR® lens indicated that posterior capsule opacification (PCO), when present, developed earlier into clinically significant PCO. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ ReSTOR® IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ ReSTOR® +2.5 D IOL Directions for Use (DFU).

Click here to view the AcrySof® IQ ReSTOR® +3.0 D IOL Directions for Use (DFU).

ACRYSOF® IQ RESTOR® FAMILY OF INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Lens (IOL) is intended for primary implantation for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence. The lens is intended to be placed in the capsular bag.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia, and ensure that IOL centration is achieved. Care should be taken to remove viscoelastic from the eye at the close of surgery.

Some patients may experience visual disturbances and/or discomfort due to multifocality, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. Spectacle independence rates vary with all multifocal IOLs; as such, some patients may need glasses when reading small print or looking at small objects.

Clinical studies with the AcrySof® ReSTOR® lens indicated that posterior capsule opacification (PCO), when present, developed earlier into clinically significant PCO. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof® IQ ReSTOR® IOLs.

Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof® Natural IOL and normal color vision. The effect on vision of the AcrySof® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS® or BSS PLUS® Sterile Intraocular Irrigating Solutions.

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.

Click here to view the AcrySof® IQ ReSTOR® +2.5 D IOL Directions for Use (DFU).

Click here to view the AcrySof® IQ ReSTOR® +3.0 D IOL Directions for Use (DFU).